• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $HAPP

    Happiness Development Group Limited

    Subscribe to $HAPP
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.

    IPO Year: 2019

    Exchange: NASDAQ

    Website: happ.org.cn

    Recent Analyst Ratings for Happiness Development Group Limited

    DatePrice TargetRatingAnalyst
    See more ratings

    Happiness Development Group Limited SEC Filings

    View All

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/23/24 4:15:34 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/12/24 4:15:56 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    12/5/23 5:25:25 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form EFFECT filed by Happiness Development Group Limited

    EFFECT - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    12/5/23 12:15:09 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form F-3 filed by Happiness Development Group Limited

    F-3 - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    11/16/23 4:15:58 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    11/15/23 9:00:05 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 20-F/A filed by Happiness Development Group Limited (Amendment)

    20-F/A - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    9/26/23 9:54:17 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    9/5/23 4:15:29 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    8/23/23 4:15:14 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 20-F filed by Happiness Development Group Limited

    20-F - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    7/27/23 4:16:04 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Press Releases

    Fastest customizable press release news feed in the world

    View All

    Happiness Development Group Limited Announces Name Change to Paranovus Entertainment Technology Ltd.

    NANPING, China, March 13, 2023 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) is pleased to announce that effective on March 14, 2023, the Company will change its name to "Paranovus Entertainment Technology Ltd.", which better reflects the Company's strategic business expansion and less limiting than the current name. In connection with the name change, the trading symbol of the Class A ordinary shares will be changed to "PAVS" on the Nasdaq Stock Market, effective on March 14, 2023. Xuezhu Wang, the CEO and the Chairman of the Board of the Company, commented, "This new name will reflect the company's evolving focus and strategy. The company is p

    3/13/23 9:10:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

    NANPING, China, Oct. 27, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) announced today that on October 25, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On November 11, 2021, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until May 10, 2

    10/27/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Announces 1 for 20 Reverse Share Split

    NANPING, China, Oct. 10, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that an 1 for 20 reverse split of its ordinary shares, par value $0.0005 each, was approved by the Company's shareholders on October 7, 2022 and became effective on October 10, 2022. In connection with the reverse share split, the Company's shareholders will receive one new ordinary share of the Company for every twenty shares they hold. The Company's o

    10/10/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Entered into Agreement for Sales up to 2000 Electric Vehicles

    NANPING, China, May 25, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that its automobile sales subsidiary 'Taochejun" has entered into a strategic cooperation agreement with Fujian Yiluba Automobile Service Consulting Co., Ltd. ("168"). According to the cooperation agreement, over the next three years, 168 plans to purchase from Taochejun up to 2,000 new energy vehicles. If 168 purchases all of the 2,000 vehicles, the tot

    5/25/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

    NANPING, China, May 16, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, of e-commerce and providing marketing solutions, and of the sales of automobile, today announced that on May 11, 2022, the Company received a written notification from the Nasdaq's Listing Qualifications Department, granting the Company another 180 calendar days extension, or until November 7, 2022, to regain compliance with Nasdaq's minimum bid price requirement. The Company can cure this deficiency if the closing bid price of its Class A ordinary

    5/16/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Donated Anti-epidemic Materials to Minhang District, Shanghai

    NANPING, China, April 13, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and  marketing solutions, and the sales of automobile today announced that the Company has donated RMB 200,000 worth of anti-epidemic materials such as alcohol disinfectant and RMB 30,000 worth of vegetables to Minhang District, Shanghai to battle COVID-19. "At this difficult time, the whole society is making efforts to fight the epidemic. As a listed company, we hope to make our own contribution to this battle. This ba

    4/13/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Announces $6.7 Million Registered Direct Offering To Support Its Auto Business

    NANPING, China, March 11, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced that it has entered into a securities purchase agreement with certain non-U.S. strategic investors for a registered direct placement of approximately $6.7 million, pursuant to which the Company agreed to sell 19.2 million Class A ordinary shares at a per share purchase price of $0.35. The Company intends to use the gross proceeds in the development o

    3/11/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Entered into Letter of Intent to Invest $6 Million in Kannaba Agritech Corp., A Global Cannabis Company

    NANPING, China, March 9, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobiles today announced that the Company has entered a non-binding letter of intent with Kannaba Agritech Corp. ("Kannaba"), a Cannabis company headquartered in Vancouver, Canada to purchase 10% equity interests of Kannaba for a consideration of $6 million. The Company is entering the cannabis industry as it is growing exponentially. According to a report by Prohibition Pa

    3/9/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development to Acquire Hekangyuan, One of the Largest Healthcare Product Distributors in Fuzhou Area in China

    NANPING, China, March 7, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced that it has signed an equity transfer agreement (the "Agreement") to acquire 100% of the equity interest in Fuzhou Hekangyuan Trading Co., Ltd. ("Hekangyuan") to further strengthen the distribution network of the Company. Hekangyuan believes that it is one of largest healthcare product distributors in Fuzhou, China. Hekangyuan generated revenue of $17

    3/7/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Announces $10 Million Private Placement to Support Its International Expansion

    NANPING, China, Jan. 21, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced it has entered into certain securities purchase agreement with several non-U.S. strategic investors to sell total 12,500,000 Class A ordinary shares at a per share purchase price of $0.80, with over 45% premium to the market price of its Class A ordinary shares. The Company intends to use the gross proceeds to expand its international e-commerce sales for its curr

    1/21/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Financials

    Live finance-specific insights

    View All

    Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

    NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced its unaudited financial results for the six months ended September 30, 2021. Financial Highlights for the six months ended September 30, 2021: Revenues increased by $25.01 million or 114.3%, to $46.88 million for the six months ended September 30, 2021 from $21.88 million for the six months ended September 30, 2020, mainly due to the start-up of new goods or service

    1/6/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Acquires Majority Ownership in Fujian Shennong

    NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited ((the ", Company", NASDAQ:HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration. Fujian Shennong is a company with a solid customer's base, focusing on the trading of a

    10/25/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

    NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2020 and provided the guidance for the whole fiscal year ending March 31, 2021. Financial Highlights for the six months ended September 30, 2020: Revenues decreased by $9.48 million or 30.2%, to $21.88 million for the six months ended September 30, 2020 from $31.36 million for the six months ended September 30, 2019, mainly due to the declining retail market affected by the COVID-19. Operating income was $3.69 million fo

    1/22/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:48:39 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:52:26 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Happiness Development Group Limited (Amendment)

    SC 13D/A - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    7/28/23 4:15:28 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care